Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Adherium Ltd. ( (AU:ADR) ) has issued an update.
Adherium Limited announced the cessation of certain securities, including 394,753 ordinary fully paid shares and 3,600,447 stock appreciation rights, due to unmet conditions and the expiry of options. This announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and future growth prospects.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on developing digital health technologies. The company primarily offers solutions that enhance medication adherence and provide remote monitoring for patients with chronic respiratory conditions.
YTD Price Performance: -28.57%
Average Trading Volume: 940,510
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$6.83M
See more insights into ADR stock on TipRanks’ Stock Analysis page.